findmyKOL

Douglas Orr, MD

Basic profile

Mary Crowley Cancer Research Center

ORCIDNone on fileNPI
RegionDallas, TX · South CentralSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Douglas Orr is an Oncology physician affiliated with Mary Crowley Cancer Research Center. OpenAlex indexes 31 publications with 1,893 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex.

1,893citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    59.3%
    PD-1 inhibitor38.9%
    Pembrolizumab78%Nivolumab22%
    Part B, office-administered44 patients
    Microtubule Inhibitor12.7%
    Paclitaxel100%
    Part B, office-administered26 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    27.2%
    Other antiemetics23.4%
    Fosaprepitant100%
    Part B, office-administered42 patients
    Serotonin-3 Receptor Antagonist3.6%
    Palonosetron hcl59%Granisetron hydrochloride41%
    Part B, office-administered57 patients

    + 1 more class in this area

  • Blood & clotting

    9.4%
    Parenteral Iron Replacement9.4%
    Iron sucrose100%
    Part B, office-administered16 patients
Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”